ENROFLOXACIN 100- enrofloxacin injection, solution

Ülke: ABD

Dil: İngilizce

Kaynak: NLM (National Library of Medicine)

Aktif bileşen:

enrofloxacin (UNII: 3DX3XEK1BN) (enrofloxacin - UNII:3DX3XEK1BN)

Mevcut itibaren:

BUTLER ANIMAL HEALTH SUPPLY, LLC dba COVETRUS NORTH AMERICA

Uygulama yolu:

SUBCUTANEOUS

Reçete türü:

PRESCRIPTION

Terapötik endikasyonlar:

Cattle - Single-Dose Therapy: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Cattle - Multiple-DayTherapy: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle. Swine: Enrofloxacin 100 Injection is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Enrofloxacin 100 injection is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.

Ürün özeti:

Enrofloxacin 100 Injection:

Yetkilendirme durumu:

Abbreviated New Animal Drug Application

Ürün özellikleri

ENROFLOXACIN 100- ENROFLOXACIN INJECTION, SOLUTION
BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA
----------
COVETRUS
Approved by FDA under ANADA # 200-495
ENROFLOXACIN 100 INJECTION
(ENROFLOXACIN)
100 MG/ML ANTIMICROBIAL
INJECTABLE SOLUTION
For Subcutaneous Use In Beef Cattle And Non-Lactating Dairy Cattle
For Intramuscular Or Subcutaneous Use In Swine
Not For Use In Female Dairy Cattle 20 Months Of Age Or Older Or In
Calves To Be
Processed For Veal
CAUTION:
Federal (U.S.A.) law restricts this drug to use by or on the order of
a licensed
veterinarian.
Federal (U.S.A.) law prohibits the extra-label use of this drug in
food-producing animals.
To assure responsible antimicrobial drug use, enrofloxacin should only
be used as a
second-line drug for colibacillosis in swine following consideration
of other therapeutic
options.
PRODUCT DESCRIPTION:
Enrofloxacin 100 Injection is a sterile, ready-to-use injectable
antimicrobial solution that
contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial
agent.
Each mL of Enrofloxacin 100 Injection contains 100 mg of enrofloxacin.
Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl
alcohol (as a
preservative) 20 mg and water for injection q.s.
CHEMICAL NOMENCLATURE AND STRUCTURE:
1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,
4-dihydro-4-oxo-3-quinolinecarboxylic
acid.
INDICATIONS:
CATTLE - SINGLE-DOSE THERAPY: Enrofloxacin 100 Injection is indicated
for the
treatment of bovine respiratory disease (BRD) associated with
_Mannheimia haemolytica,_
®
_Pasteurella multocida, Histophilus somni_ and _Mycoplasma bovis_ in
beef and non-lactating
dairy cattle; and for the control of BRD in beef and non-lactating
dairy cattle at high risk
of developing BRD associated with _M. haemolytica, P. multocida, H.
somni_ and _M. bovis._
CATTLE - MULTIPLE-DAYTHERAPY: Enrofloxacin 100 Injection is indicated
for the
treatment of bovine respiratory disease (BRD) associated with
_Mannheimia haemolytica,_
_Pasteurella multocida_ and _Histophilus somni_ in